SCHEMBL27775630

SCHEMBL27775630

CN1CCN(CC(=O)c2ccc3c(c2)OC(C=O)N3)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 2/20 0.42
▸ ALDH1A1 P00352 9/20 0.42
▸ KDM4E B2RXH2 4/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ CNR2 P34972 1/20 0.41
▸ CYP2C9 P11712 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ MAPT P10636 4/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ PARP1 P09874 1/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ HSD17B10 Q99714 2/20 0.37
▸ HPGD P15428 3/20 0.36
▸ PDE5A O76074 1/20 0.36
▸ ALPL P05186 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27775556 0.90 ALDH1A1 (0.45) MAOBALDH1A1KDM4ENPC1LMNA
SCHEMBL28274463 0.78 ALDH1A1 (0.42) ALDH1A1KDM4ESMN1; SMN2MAPTMAPK1
SCHEMBL27685360 0.78 PTPN1 (0.39) —
SCHEMBL27794009 0.77 HRH3 (0.45) ALDH1A1KDM4ELMNARAB9ACYP2C19
SCHEMBL27717446 0.76 KDM4E (0.39) ALDH1A1KDM4ENPC1RAB9AALOX15
SCHEMBL27459025 0.76 HPGD (0.33) ALDH1A1MAPTHPGD
SCHEMBL28785094 0.73 ALDH1A1 (0.38) MAOBALDH1A1KDM4ENPC1LMNA
SCHEMBL27711108 0.73 PARP1 (0.45) PARP1
SCHEMBL28788261 0.72 TSHR (0.36) MAOBALDH1A1NPC1LMNAMAPT
SCHEMBL9356659 0.69 ALPG (0.70) ALDH1A1KDM4ECNR2MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101679401-B 2-oxo-3-benzyl-benzoxazol-2-one derivatives and related compounds as MET kinase inhibitors for the treatment of tumors MERCK PATENT GMBH 2012-12-12 — — CN disclosed
CN-101679401-A 2-oxo-3-benzyl-benzoxazol-2-one derivatives and related compounds as MET kinase inhibitors for the treatment of tumors MERCK PATENT GMBH 2010-03-24 — — CN disclosed
Send feedback